Ascentage Pharma Group International - Unsponsored ADR (AAPG) vs ArriVent BioPharma, Inc. (AVBP)

Ascentage Pharma Group International - Unsponsored ADR and ArriVent BioPharma, Inc. are both Biotechnology companies. Ascentage Pharma Group International - Unsponsored ADR and ArriVent BioPharma, Inc. are of similar size ($1.5B and $1.4B). Across the 7 metrics below, Ascentage Pharma Group International - Unsponsored ADR leads on 4 and ArriVent BioPharma, Inc. on 3.

Valuation

Metric AAPG AVBP Biotechnology median
P/E — n/m 7.88
P/S — n/m 11.47
P/B n/m 3.69 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield — (12.72%) (28.84%)
Free cash flow yield 0.00% (10.92%) (23.03%)

Profitability

Metric AAPG AVBP Biotechnology median
Gross margin — — 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (53.10%) (57.72%)
Return on assets 0.00% (49.30%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AAPG AVBP Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (177.78%) (68.75%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AAPG AVBP Biotechnology median
Debt to equity 3.70 0.00 0.00
Current ratio 1.22 14.16 4.73
Net debt to EBITDA 0.44 1.73 0.96

Dividend

Metric AAPG AVBP Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric AAPG AVBP Biotechnology median
Market cap 1.40b 1.48b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack